Locatelli, Francesco http://orcid.org/0000-0002-7505-261X
Minutolo, Roberto
De Nicola, Luca
Del Vecchio, Lucia
Article History
Accepted: 11 September 2022
First Online: 9 November 2022
Declarations
:
: This article received no funding.
: FL is a member of an Advisory Board of Amgen, Astellas, Baxter, GSK, Otsuka, Travere and Vifor Pharma and was speaker at meetings supported by Amgen, Astellas, Vifor Pharma. RM received speaker fees at meeting supported directly or indirectly by Amgen, Astellas, Bayer and Vifor Pharma. In the last two years he participated to Advisory Boards for Amgen, Astellas and GSK. LDN received speaker fees at meeting supported directly or indirectly by Amgen, Astellas and Vifor Pharma. In the last two years he participated to Advisory Boards for Astellas, GSK and Otsuka. LDV received speaker fees at meeting supported directly or indirectly by Astellas and Vifor Pharma. In the last two years she participated in Advisory Boards for Travere. She had been National Leader for the ASCEND-ND study. All the authors contributed to the writing and revision of the manuscript.
: Not applicable.
: Not applicable.
: Not applicable.
: Data sharing not applicable to this article as no datasets were generated or analysed during the current study.
: Not applicable.
: The authors contributed equally to the manuscript.
Free to read: This content has been made available to all.